Skip to main content

ADVERTISEMENT

Edward V. Loftus, Jr., MD

BACKGROUND: Limited knowledge exists as to what impact preoperative biologic therapy has on post-operative complications in pediatric patients undergoing abdominal surgery for Crohn’s dis...
11/20/2018
BACKGROUND: Limited knowledge exists as to what impact preoperative biologic therapy has on post-operative complications in pediatric patients undergoing abdominal surgery for Crohn’s dis...
11/20/2018
Podcasts
11/09/2023
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details...
11/09/2023
Pharmacy Learning Network
1 Mayo Clinic, Rochester, Minnesota, United States; 2 Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States.
01/11/2024
IBD Drive Time Logo
Podcast
09/05/2023
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details...
09/05/2023
Advances in Inflammatory Bowel Disease Network